Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results-Reference-Cited by-同舟云学术

Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results

Published:2020-12-28 Issue:4 Volume:51 Page:943-955
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Hauser Ingeborg A.¹,Marx Stefanie²,Sommerer Claudia³,Suwelack Barbara⁴,Dragun Duska⁵,Witzke Oliver⁶,Lehner Frank⁷⁸,Schiedel Christiane⁹,Porstner Martina⁹,Thaiss Friedrich¹⁰,Neudörfl Christine¹¹,Falk Christine S.¹¹¹²,Nashan Björn¹³¹⁴,Sester Martina²^ORCID

Affiliation:

1. Department of Nephrology Goethe‐University Frankfurt Frankfurt Germany

2. Department of Transplant and Infection Immunology Saarland University Homburg Germany

3. Nephrology Unit University Hospital Heidelberg Heidelberg Germany

4. Department of Internal Medicine Transplant Nephrology University Hospital of Münster Münster Germany

5. Department of Nephrology and Intensive Care Medicine Charité Universitätsmedizin Berlin Berlin Germany

6. Department of Infectious Diseases West German Centre of Infectious Diseases Universitätsmedizin Essen University Duisburg‐Essen Duisburg‐Essen Germany

7. Clinic for General Abdominal and Transplant Surgery Hannover Medical School Hannover Germany

8. Helios Hospital Hildesheim Department of General‐ and Visceral Surgery Academic Teaching Hospital of the Hannover Medical School Hildesheim Germany

9. Novartis Pharma GmbH Nürnberg Germany

10. Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

11. Institute of Transplant Immunology Hannover Medical School MHH Hannover Germany

12. German Center for Infection Research DZIF Hannover Germany

13. Department of Hepatobiliary Surgery and Transplantation University Medical Center Hamburg‐Eppendorf Hamburg Germany

14. Organ Transplantation Center The First Affiliated Hospital of University of Science and Technology of China Anhui Provincial Hospital Hefei China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202048855

Reference50 articles.

1. Common Infections in Kidney Transplant Recipients

2. Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients

3. PD-1 Analysis on CD28−CD27−CD4 T Cells Allows Stimulation-Independent Assessment of CMV Viremic Episodes in Transplant Recipients

4. Fewer cytomegalovirus complications after kidney transplantation byde novouse of mTOR inhibitors in comparison to mycophenolic acid

5. PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional Anergy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV;Transplant International;2024-04-09

2. Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy;Frontiers in Transplantation;2023-11-21

3. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

4. The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-04-10

5. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma;Nature Communications;2022-10-27